TLR8 and neoplasm: Notably, CD4+regulatory T (Treg) cells can suppress the body's immune responses, while TLR8 can activate the TLR8-MyD88-IRAK4 signaling pathway through recognition of ligands to inhibit the immunosuppressive function of Treg cells, thereby enhancing the body's anti-tumour immunity [16].